Approval · Notice of Compliance 8928 · 2007
ORENCIA: Notice of Compliance 8928
Issued July 23, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8928
- Date
- July 23, 2007
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Selective co-stimulation modulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORENCIA | Not yet assigned | — |
Medicinal ingredients
- ABATACEPT 250 MG per VIAL